These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34725696)

  • 1. Clinical trial challenges, design considerations, and outcome measures in rare CNS tumors.
    Armstrong TS; Gilbert MR
    Neuro Oncol; 2021 Nov; 23(23 Suppl 5):S30-S38. PubMed ID: 34725696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches to improve the treatment of rare gynecologic cancers: research opportunities and challenges.
    Ledermann JA; Ray-Coquard I
    Am Soc Clin Oncol Educ Book; 2014; ():e282-6. PubMed ID: 24857114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilizing preclinical models to develop targeted therapies for rare central nervous system cancers.
    Arakaki AKS; Szulzewsky F; Gilbert MR; Gujral TS; Holland EC
    Neuro Oncol; 2021 Nov; 23(23 Suppl 5):S4-S15. PubMed ID: 34725698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations for the design of small population clinical trials.
    Day S; Jonker AH; Lau LPL; Hilgers RD; Irony I; Larsson K; Roes KC; Stallard N
    Orphanet J Rare Dis; 2018 Nov; 13(1):195. PubMed ID: 30400970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgeons: A Future Role in Clinical Trials?
    Rusch VW
    Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current state of therapeutic development for rare cancers in Japan, and proposals for improvement.
    Kawai A; Goto T; Shibata T; Tani K; Mizutani S; Nishikawa A; Shibata T; Matsumoto S; Nagata K; Narukawa M; Matsui S; Ando M; Toguchida J; Monden M; Heike T; Kimura S; Ueda R
    Cancer Sci; 2018 May; 109(5):1731-1737. PubMed ID: 29878624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force Report.
    Benjamin K; Vernon MK; Patrick DL; Perfetto E; Nestler-Parr S; Burke L
    Value Health; 2017; 20(7):838-855. PubMed ID: 28712612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma Workshop.
    Penas-Prado M; Wu J; Cahill DP; Brat DJ; Costello JF; Kluetz PG; Cairncross JG; van den Bent M; Verhaak RGW; Aboud O; Burger P; Chang SM; Cordova C; Huang RY; Rowe LS; Taphoorn MJB; Gilbert MR; Armstrong TS;
    Neurooncol Adv; 2020; 2(1):vdz048. PubMed ID: 33289010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments for astrocytic tumors in children: current and emerging strategies.
    Burzynski SR
    Paediatr Drugs; 2006; 8(3):167-78. PubMed ID: 16774296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial methodology in rare gynecologic tumor research: Strategies for success.
    Brown J; Naumann RW; Brady WE; Coleman RL; Moore KN; Gershenson DM
    Gynecol Oncol; 2018 Jun; 149(3):605-611. PubMed ID: 29699802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical review of the management of primary central nervous nongerminomatous germ cell tumors.
    Abu Arja MH; Bouffet E; Finlay JL; AbdelBaki MS
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27658. PubMed ID: 30767415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare Primary Central Nervous System Tumors in Adults: An Overview.
    Franceschi E; Frappaz D; Rudà R; Hau P; Preusser M; Houillier C; Lombardi G; Asioli S; Dehais C; Bielle F; Di Nunno V; van den Bent M; Brandes AA; Idbaih A;
    Front Oncol; 2020; 10():996. PubMed ID: 32676456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statistical and trial design considerations in central nervous system prophylaxis studies.
    Smith JA; Glantz M
    Semin Oncol; 2009 Aug; 36(4 Suppl 2):S69-76. PubMed ID: 19660685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumors of the central nervous system in children and adolescents.
    Frühwald MC; Rutkowski S
    Dtsch Arztebl Int; 2011 Jun; 108(22):390-7. PubMed ID: 21712972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.